Region: China

SAMR punishes drug wholesalers for price-fixing cancer treatment injections

China’s antitrust watchdog has fined two drug wholesalers €7.5 million for price-fixing and dividing the market for a cancer treatment injection, continuing its aggressive enforcement in the pharmaceutical sector.

05 June 2023

China sanctions gas utility for illegal tying and charging excessive prices

A Chinese domestic gas utility must pay roughly €6.6 million for abusing its dominance in the natural gas pipeline supply service market, after unlawfully tying its pipeline projects with its other services and charging unjustly high installation fees.

05 June 2023

China sanctions pharmaceutical company for RPM over contraceptives

China’s State Administration for Market Regulation has fined a pharmaceutical company €1.7 million for fixing the resale price of two widely-used emergency contraceptives for six years.

01 June 2023

AnJie founding partner joins Hylands Law Firm

Michael Gu, a founding partner at AnJie Law Firm, has moved to Hylands Law Firm to help establish its antitrust practice.

01 June 2023

China issues first joint cartel and abuse fine to epinephrine maker

China’s competition authority has for the first time ever sanctioned a company for cartel conduct and abuse of dominance in a single case – slapping an active pharmaceutical ingredient supplier with a €37.7 million penalty.

31 May 2023

China set to loosen foreign investment restrictions

China plans to allow increased foreign investment in sensitive sectors to continue promoting the opening up of its economy, the National Development and Reform Commission has said.

21 April 2023

AnJie Broad Law Firm adds partner in China

Wang Zhining, the former head of antitrust compliance at Chinese consumer electronics company Xiaomi, has rejoined AnJie Broad Law Firm as a partner in Beijing.

18 April 2023

SAMR approves domestic chemical deal with FRAND commitments

China’s antitrust authority has approved Wanhua Chemical Group’s acquisition of a domestic rival subject to extensive behavioural remedies, which include pricing commitments and supplying domestic customers on fair, reasonable and non-discriminatory terms.

12 April 2023

SAMR delaying merger reviews involving US tech companies

China’s antitrust authority has reportedly slowed down its reviews of several transactions involving acquisitions by US technology companies as the trade relationship between the world’s two largest economies remains strained.

06 April 2023

Linklaters promotes in US, Europe and China

Linklaters has added Marcus Pollard and William Leslie to its respective partnerships in Hong Kong and Brussels, while also promoting a lawyer at an affiliate firm in China and adding five new counsel in Europe and the US.

03 April 2023

Unlock unlimited access to all Global Competition Review content